Global Inhaled Nitric Oxide Market to Grow at a CAGR of 8.1% During 2024-2032, Aided by the Increasing Focus on Addressing Significant Unmet Medical Needs in the Treatment of Cardiopulmonary Diseases

The global market for inhaled nitric oxide is being driven by the rapid development of healthcare infrastructure, especially in emerging economies. This can be attributed to the rising healthcare expenditure, increasing government spending on public health, and rising disposable income of the population. Over the forecast period, the market is anticipated to be aided by the changing patient preference towards minimally-invasive treatments, which bolster the safety of geriatrics and infants, who are extremely sensitive to intense surgeries. Inhaled nitric oxide helps the body relax, bolsters the muscle toning, and helps the body absorb maximum amount of oxygen.

In April 2020, Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) announced the submission of an investigational new drug application to the U.S FDA to study INOpulse®, an inhaled nitric oxide therapy for the treatment of COVID-19. INOpulse® is known to be the only therapy to deliver targeted nitric oxide as it autonomously adjusts to the breathing pattern to ensure accurate and consistent drug delivery into the airways of patients. PULSE-CVD19-001, a randomised and open label study, will evaluate and determine the efficacy and safety of INOpulse® in patients with COVID-19, experiencing a deficiency of oxygen.

In terms of region, the Asia Pacific is likely to account for a significant share of the market, owing to the growing population and the increasing incidences of respiratory diseases and breathing problems in the region. The rapid technological advancements in the healthcare infrastructure, growing urbanisation, and increasing clinical trials and research activities to develop better medications and treatments are likely to provide impetus to the market in the coming years.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Application and Region:

• The market is segmented based on application into neonatal respiratory treatment, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS), among others.

• Region-wise, the global market for inhaled nitric oxide can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The global market for inhaled nitric oxide is being supported by the increasing development of hospitals, ambulatory surgical centres, and advanced clinics to address significant unmet medical needs.

• The market is anticipated to be driven by the rising cases of pulmonary hypertension, neonatal hypoxic respiratory failure, and respiratory distress syndrome, among others. 

• The market is anticipated to be augmented by the rising healthcare spending and increasing government expenditure on public health. 

• The market is further expected to be aided by the growing research and development activities by the leading biotherapeutics companies to develop innovative inhaled nitric oxide therapies.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for inhaled nitric oxide for the periods (2018-2023) and (2024-2032). 

• The report also offers historical (2018-2023) and forecast (2024-2032) market information for the applications and regions of inhaled nitric oxide.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global inhaled nitric oxide market are Bellerophon Therapeutics Inc., Air Liquide Group, BOC Limited, and Vero Biotech, LLC, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790